Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation

Hematology

Volumn 14, Issue 2, 2009, Pages 63-72

  Liu, Qi Fa ^a   Luo, Xiao Dan ^a   Ning, Juan ^a   Xu, Dan ^a   Fan, Zhi Ping ^a   Sun, Jing ^a   Zhang, Yu ^a   Xu, Bing ^a   Wei, Yong Qiang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Acute graft versus host disease; Allogeneic haematopoietic stem cell transplantation; Lung injury

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; GAMMA INTERFERON; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL DAMAGE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROPERICARDIUM; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; LUNG INJURY; MALE; PERICARDIAL DISEASE; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT DURATION; TREATMENT RESPONSE;

ACUTE DISEASE; ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; LUNG INJURY; MALE; MIDDLE AGED; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 66949152966     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X385142     Document Type: Article

References (19)

1. Bolanos-Meade J, Ioffe O, Hey JC, Vogelsang GB, Akpek G. Lymphocytic pneumonitis as the manifestation of acute graftversus- host disease of the lung. Am J Hematol 2005; 79: 132-135.
2. Cooke KR, Krenger W, Hill G et al. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 1998; 92: 2571-2580.
3. Yanik G, Cooke KR. The lung as a target organ of graft-versushost disease. Semin Hematol 2006; 43: 42-52.
4. Beschorner WE, Saral R, Hutchins GM, Tutschka PJ, Santos GW. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med 1978; 299: 1030-1036.
5. Hildebrandt GC, Olkiewicz KM, Corrion LA et al. Donor-derived TNFα regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 2004; 104: 586-593.
6. Cooke KR, Hill GR, Gerbitz A et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000; 70: 272-279.
7. Liu QF, Xun J, Xu D et al. Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia. J First Mil Med Univ 2004; 24: 1117-1119.
8. Apperley J, Carreras E, Gluckman E. The EBMT handbook 2004 revised edition: Haemopoietic stem cell transplantation. Genoa: Forum Service Editore, 2004; 163-176.
9. Yoshihara S, Yanik G, Cooke KR, Mineishi S. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 749-759.
10. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425-434.
11. Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC. Association between acute and chronic graftversus- host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003; 102: 3822-3828.
12. Hakim FT, Mackall CL. The immune system: Effector and target of graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ. (eds) Graft-vs.-host disease second edition. New York: Marcel Dekker, 1997; 257.
13. Knox KS, Behnia M, Smith LR et al. Acute graft-versus-host disease of the lung after liver transplantation. Liver Transplant 2002; 8: 968-971.
14. Shankar G, Cohen DA. Idiopathic pneumonia syndrome after bone marrow transplantation: The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol 2001; 82: 101-113.
15. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601-1606.
16. Yen KT, Lee AS, Krowka MJ, Burger CD. Pulmonary complications in bone marrow transplantation: A practical approach to diagnosis and treatment. Clin Chest Med 2004; 25: 189-201.
17. Watkins TR, Chien JW, Crawford SW. Graft versus hostassociated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med 2005; 26: 482-489.
18. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996; 109: 1066-1077.
19. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223-229.